MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease

Science Translational Medicine

Volumn 6, Issue 239, 2014, Pages

  Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 122; RNA INDUCED SILENCING COMPLEX; BIOLOGICAL MARKER;

3' UNTRANSLATED REGION; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC REGULATION; HEART DEVELOPMENT; HEART MUSCLE CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CANCER; MULTIGENE FAMILY; NONHUMAN; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; RNA PROCESSING; RNA STABILITY; RNA TRANSLATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE REGENERATION; VIRUS GENOME; ANTAGONISTS AND INHIBITORS; BLOOD; CARDIOVASCULAR DISEASES; EMBRYOLOGY; GENETICS; HEART; MOLECULARLY TARGETED THERAPY; REGENERATION;

BIOMARKERS; CARDIOVASCULAR DISEASES; HEART; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; REGENERATION;

EID: 84903166837     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009008     Document Type: Review

References (28)

1. E. M. Small, E. N. Olson, Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336-342 (2011).
2. A. Bonauer, R. A. Boon, S. Dimmeler, Vascular microRNAs. Curr. Drug Targets 11, 943-949 (2010).
3. K. R. Cordes, D. Srivastava, MicroRNA regulation of cardiovascular development. Circ. Res. 104, 724-732 (2009).
4. D. G. Hendrickson, D. J. Hogan, H. L. McCullough, J. W. Myers, D. Herschlag, J. E. Ferrell, P. O. Brown, Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLOS Biol. 7, e1000238 (2009).
5. E. van Rooij, D. Quiat, B. A. Johnson, L. B. Sutherland, X. Qi, J. A. Richardson, R. J. Kelm Jr., E. N. Olson, A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 17, 662-673 (2009).
6. D. P. Bartel, MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
7. J. T. Mendell, E. N. Olson, MicroRNAs in stress signaling and human disease. Cell 148, 1172-1187 (2012).
8. G. W. Dorn, 2nd, S. J. Matkovich, W. H. Eschenbacher, Y. Zhang, A human 3′ miR-499 mutation alters cardiac mRNA targeting and function. Circ. Res. 110, 958-967 (2012).
9. P. Arora, C. Wu, A. M. Khan, D. B. Bloch, B. N. Davis-Dusenbery, A. Ghorbani, E. Spagnolli, A. Martinez, A. Ryan, L. T. Tainsh, S. Kim, J. Rong, T. Huan, J. E. Freedman, D. Levy, K. K. Miller, A. Hata, F. Del Monte, S. Vandenwijngaert, M. Swinnen, S. Janssens, T. M. Holmes, E. S. Buys, K. D. Bloch, C. Newton-Cheh, T. J. Wang, Atrial natriuretic peptide is negatively regulated by microRNA-425. J. Clin. Invest. 123, 3378-3382 (2013).
10. E. Dirkx, M. M. Gladka, L. E. Philippen, A. S. Armand, V. Kinet, S. Leptidis, H. El Azzouzi, K. Salic, M. Bourajjaj, G. J. da Silva, S. Olieslagers, R. van der Nagel, R. de Weger, N. Bitsch, N. Kisters, S. Seyen, Y. Morikawa, C. Chanoine, S. Heymans, P. G. Volders, T. Thum, S. Dimmeler, P. Cserjesi, T. Eschenhagen, P. A. da Costa Martins, L. J. De Windt, Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat. Cell Biol. 15, 1282-1293 (2013).
11. C. Wahlquist, D. Jeong, A. Rojas-Muñoz, C. Kho, A. Lee, S. Mitsuyama, A. van Mil, W. J. Park, J. P. Sluijter, P. A. Doevendans, R. J. Hajjar, M. Mercola, Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 508, 531-535 (2014).
12. T. Thum, C. Gross, J. Fiedler, T. Fischer, S. Kissler, M. Bussen, P. Galuppo, S. Just, W. Rottbauer, S. Frantz, M. Castoldi, J. Soutschek, V. Koteliansky, A. Rosenwald, M. A. Basson, J. D. Licht, J. T. Pena, S. H. Rouhanifard, M. U. Muckenthaler, T. Tuschl, G. R. Martin, J. Bauersachs, S. Engelhardt, MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
13. D. M. Patrick, R. L. Montgomery, X. Qi, S. Obad, S. Kauppinen, J. A. Hill, E. van Rooij, E. N. Olson, Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest. 120, 3912-3916 (2010).
14. E. van Rooij, L. B. Sutherland, J. E. Thatcher, J. M. DiMaio, R. H. Naseem, W. S. Marshall, J. A. Hill, E. N. Olson, Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U.S.A. 105, 13027-13032 (2008).
15. R. A. Boon, T. Seeger, S. Heydt, A. Fischer, E. Hergenreider, A. J. Horrevoets, M. Vinciguerra, N. Rosenthal, S. Sciacca, M. Pilato, P. van Heijningen, J. Essers, R. P. Brandes, A. M. Zeiher, S. Dimmeler, MicroRNA-29 in aortic dilation: Implications for aneurysm formation. Circ. Res. 109, 1115-1119 (2011).
16. Z. Lin, W.T. Pu, Strategies for cardiac regeneration and repair. Sci. Transl. Med. 6, 239rv1(2014).
17. E. R. Porrello, B. A. Johnson, A. B. Aurora, E. Simpson, Y. J. Nam, S. J. Matkovich, G. W. Dorn 2nd, E. van Rooij, E. N. Olson, MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ. Res. 109, 670-679 (2011).
18. A. Eulalio, M. Mano, M. Dal Ferro, L. Zentilin, G. Sinagra, S. Zacchigna, M. Giacca, Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381 (2012).
19. J. Chen, Z. P. Huang, H. Y. Seok, J. Ding, M. Kataoka, Z. Zhang, X. Hu, G. Wang, Z. Lin, S. Wang, W. T. Pu, R. Liao, D. Z. Wang, mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ. Res. 112, 1557-1566 (2013).
20. E. E. Creemers, A. J. Tijsen, Y. M. Pinto, Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 110, 483-495 (2012).
21. V. Kinet, J. Halkein, E. Dirkx, L. J. Windt, Cardiovascular extracellular microRNAs: Emerging diagnostic markers and mechanisms of cell-to-cell RNA communication. Frontiers in genetics 4, 214 (2013).
22. A. Schober, M. Nazari-Jahantigh, Y. Wei, K. Bidzhekov, F. Gremse, J. Grommes, R. T. Megens, K. Heyll, H. Noels, M. Hristov, S. Wang, F. Kiessling, E. N. Olson, C. Weber, Mi-croRNA- 126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat. Med. 20, 368-376 (2014).
23. E. Hergenreider, S. Heydt, K. Tréguer, T. Boettger, A. J. Horrevoets, A. M. Zeiher, M. P. Scheffer, A. S. Frangakis, X. Yin, M. Mayr, T. Braun, C. Urbich, R. A. Boon, S. Dimmeler, Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14, 249-256 (2012).
24. J. Krützfeldt, N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan, M. Stoffel, Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005).
25. E. van Rooij, A. L. Purcell, A. A. Levin, Developing microRNA therapeutics. Circ. Res. 110, 496-507 (2012).
26. R. E. Lanford, E. S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, M. E. Munk, S. Kauppinen, H. Ørum, Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201 (2010).
27. Q. Zhou, R. Gallagher, R. Ufret-Vincenty, X. Li, E. N. Olson, S. Wang, Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23-27-24 clusters. Proc. Natl. Acad. Sci. U.S.A. 108, 8287-8292 (2011).
28. H. Ling, M. Fabbri, G. A. Calin, MicroRNAs and other noncoding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 12, 847-865 (2013).